Adult-onset Still Disease
📧 Sign up to get email alerts when something new happens for Adult-onset Still Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease
A clinical trial update describing a head-to-head study of Firsekibart versus Anakinra for Adult-Onset Still's Disease, currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions
This clinical trial aims to study the natural history, genetics, and pathophysiology of systemic juvenile idiopathic arthritis and adult-ons…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
A clinical trial is evaluating canakinumab for Familial Mediterranean Fever and Still's disease (including systemic juvenile idiopathic arth…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)
This clinical trial update describes an ongoing study on the natural history, pathogenesis, and outcomes of autoinflammatory diseases includ…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD [Phase 3]
Phase 3 study evaluated the efficacy and safety of canakinumab in Japanese adults with Adult Onset Still's Disease. Results have been posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE [Phase 3]
A Phase 3 clinical trial evaluated the efficacy, safety, tolerability, and pharmacokinetics/pharmacodynamics of emapalumab in children and a…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Acostill ( RaDiCo Cohort) (RaDiCo Acostill)
A RaDiCo Acostill cohort study led by INSERM in France is currently recruiting to study Still's disease, including adult-onset Still's disea…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Assessment of Macrophage Activation syndromE in STill's Disease in Italy
A clinical trial evaluating macrophage activation syndrome in Still's disease (systemic juvenile idiopathic arthritis and adult-onset Still'…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease [NA]
This clinical trial update indicates that a study evaluating sirolimus for refractory adult-onset Still's disease is currently active but no…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Glycosylated Ferritin in Macrophagic Activation Syndromes
This clinical trial update describes a study evaluating glycosylated ferritin in macrophage activation syndrome associated with adult-onset …
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease [Phase 3]
A Phase 3 efficacy and safety trial evaluating GNR-086 (canakinumab biosimilar) versus Ilaris (canakinumab) in adults with adult-onset Still…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Clinical Autoinflammatory Disease Cohort
A RenJi Hospital-sponsored autoinflammatory disease cohort trial focusing on Still's disease is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: AutoInflammatory Disease Alliance Registry (AIDA)
The AutoInflammatory Disease Alliance Registry (AIDA) is currently recruiting to collect data on hereditary autoinflammatory diseases. The c…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD) [Phase 3]
Phase 3 clinical trial evaluating Anakinra in Japanese patients with systemic juvenile idiopathic arthritis and adult-onset Still's disease …
-
CLINICAL_TRIALS withdrawal · 2024-11-15Clinical Trial Update: Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD) [Phase 3]
A Phase 3 trial of the investigative agent RPH-104 for Adult-Onset Still's Disease has been withdrawn, and will not proceed as planned.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Assessment of Macrophage Activation syndromE in STill's Disease
A completed clinical trial assessing macrophage activation syndrome in Still's disease, including adult-onset Still's disease and juvenile-o…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Auvergne-Rhône-Alpes-Limousin Research Database for Still's Diseases in Children and Adults
Clinical trial update shows a research database for Still's disease in children and adults is currently recruiting, sponsored by Hospices Ci…
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Canakinumab for Treatment of Adult-onset Still's Disease [Phase 2]
Phase 2 trial update on canakinumab for adult-onset Still's disease (terminated; results posted).
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study [Phase 2]
A randomized Phase 2 trial evaluated the efficacy and safety of anakinra for refractory adult-onset Still's disease. The study status indica…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease [Phase 2]
A Phase 2 clinical trial evaluating Tadekinig alfa for adult-onset Still's disease has completed, providing updated results.
-
FDA approval · 2014-11-13FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for ACTEMRA (tocilizumab) submitted by Genentech, Inc. This action involves an approved product …
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Interleukin-1 Trap to Treat Autoinflammatory Diseases [Phase 2]
Phase 2 trial evaluating an Interleukin-1 trap for autoinflammatory diseases completed, with results posted in 2013, including Familial Medi…
-
CLINICAL_TRIALS trial_result · 2009-10-27Clinical Trial Update: Efficacy and Safety of Tocilizumab in Adult's Still Disease [Phase 2]
This clinical trial update reports Phase 2 results evaluating the efficacy and safety of tocilizumab in adults with adult-onset Still's dise…